Pricing Log in Create free account

Dyne Therapeutics, Inc. (DYN) vs Zai Lab Limited Unsponsored ADR (ZLAB)

Dyne Therapeutics, Inc. and Zai Lab Limited Unsponsored ADR are both Biotechnology companies. Dyne Therapeutics, Inc. and Zai Lab Limited Unsponsored ADR are of similar size ($2.9B and $2.7B). Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −41.9%) and the lower return on invested capital (−1,956.3% vs −129.3%). Across the 14 metrics below, Dyne Therapeutics, Inc. leads on 7 and Zai Lab Limited Unsponsored ADR on 7.

Valuation

Metric DYN ZLAB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5.78 9.71
P/B 3.36 4.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 4.71 9.21
Earnings yield (23.37%) (7.35%) (33.15%)
Free cash flow yield (20.38%) (6.25%) (25.50%)

Profitability

Metric DYN ZLAB Biotechnology median
Gross margin 0.00% 56.47% 65.16%
Operating margin 0.00% (58.74%) 0.00%
Net margin 0.00% (41.86%) 0.00%
Free cash flow margin 0.00% (36.13%) 0.00%
Return on equity (81.57%) (26.91%) (56.36%)
Return on assets (60.29%) (16.81%) (48.04%)
Return on invested capital (1,956.27%) (129.34%) 0.00%

Growth

Metric DYN ZLAB Biotechnology median
Revenue growth (TTM) — 5.10% 6.02%
EPS growth (last fiscal year) (2.97%) 38.46% 30.26%
Revenue growth, 5-year CAGR — 56.54% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYN ZLAB Biotechnology median
Debt to equity 0.30 0.39 0.00
Current ratio 12.02 2.13 4.72
Net debt to EBITDA 2.05 2.66 0.96

Dividend

Metric DYN ZLAB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DYN ZLAB Biotechnology median
Market cap 2.86b 2.65b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack